Addex Therapeutics (ADXN) Competitors $8.22 -0.28 (-3.24%) As of 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock ADXN vs. BRNS, AKTX, QNTM, LVTX, COEP, SCLX, SCYX, DYAI, FGEN, and MAAQShould you be buying Addex Therapeutics stock or one of its competitors? The main competitors of Addex Therapeutics include Barinthus Biotherapeutics (BRNS), Akari Therapeutics (AKTX), Quantum Biopharma (QNTM), LAVA Therapeutics (LVTX), Coeptis Therapeutics (COEP), Scilex (SCLX), SCYNEXIS (SCYX), Dyadic International (DYAI), FibroGen (FGEN), and Mana Capital Acquisition (MAAQ). These companies are all part of the "pharmaceutical products" industry. Addex Therapeutics vs. Barinthus Biotherapeutics Akari Therapeutics Quantum Biopharma LAVA Therapeutics Coeptis Therapeutics Scilex SCYNEXIS Dyadic International FibroGen Mana Capital Acquisition Barinthus Biotherapeutics (NASDAQ:BRNS) and Addex Therapeutics (NASDAQ:ADXN) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their community ranking, risk, analyst recommendations, earnings, media sentiment, dividends, profitability, institutional ownership and valuation. Is BRNS or ADXN more profitable? Addex Therapeutics has a net margin of 850.30% compared to Barinthus Biotherapeutics' net margin of 0.00%. Barinthus Biotherapeutics' return on equity of -34.26% beat Addex Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Barinthus BiotherapeuticsN/A -34.26% -29.30% Addex Therapeutics 850.30%-112.43%-77.95% Which has more volatility and risk, BRNS or ADXN? Barinthus Biotherapeutics has a beta of -0.8, suggesting that its share price is 180% less volatile than the S&P 500. Comparatively, Addex Therapeutics has a beta of 1.62, suggesting that its share price is 62% more volatile than the S&P 500. Do analysts rate BRNS or ADXN? Barinthus Biotherapeutics currently has a consensus price target of $5.17, suggesting a potential upside of 523.17%. Addex Therapeutics has a consensus price target of $30.00, suggesting a potential upside of 264.79%. Given Barinthus Biotherapeutics' higher probable upside, equities research analysts clearly believe Barinthus Biotherapeutics is more favorable than Addex Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Barinthus Biotherapeutics 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00Addex Therapeutics 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the MarketBeat Community prefer BRNS or ADXN? Barinthus Biotherapeutics received 2 more outperform votes than Addex Therapeutics when rated by MarketBeat users. Likewise, 100.00% of users gave Barinthus Biotherapeutics an outperform vote while only 51.72% of users gave Addex Therapeutics an outperform vote. CompanyUnderperformOutperformBarinthus BiotherapeuticsOutperform Votes17100.00% Underperform VotesNo VotesAddex TherapeuticsOutperform Votes1551.72% Underperform Votes1448.28% Do insiders and institutionals hold more shares of BRNS or ADXN? 25.2% of Barinthus Biotherapeutics shares are held by institutional investors. Comparatively, 16.1% of Addex Therapeutics shares are held by institutional investors. 10.7% of Barinthus Biotherapeutics shares are held by company insiders. Comparatively, 15.0% of Addex Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Which has stronger valuation and earnings, BRNS or ADXN? Addex Therapeutics has lower revenue, but higher earnings than Barinthus Biotherapeutics. Addex Therapeutics is trading at a lower price-to-earnings ratio than Barinthus Biotherapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBarinthus Biotherapeutics$14.97M2.23-$73.35M-$1.64-0.51Addex Therapeutics$556.05K15.68-$11.76M-$0.34-24.19 Does the media favor BRNS or ADXN? In the previous week, Barinthus Biotherapeutics had 3 more articles in the media than Addex Therapeutics. MarketBeat recorded 3 mentions for Barinthus Biotherapeutics and 0 mentions for Addex Therapeutics. Addex Therapeutics' average media sentiment score of 0.00 beat Barinthus Biotherapeutics' score of -0.80 indicating that Addex Therapeutics is being referred to more favorably in the news media. Company Overall Sentiment Barinthus Biotherapeutics Negative Addex Therapeutics Neutral SummaryBarinthus Biotherapeutics beats Addex Therapeutics on 10 of the 17 factors compared between the two stocks. Get Addex Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ADXN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ADXN vs. The Competition Export to ExcelMetricAddex TherapeuticsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$8.72M$6.48B$5.35B$8.38BDividend YieldN/A2.66%5.22%4.10%P/E Ratio-24.198.9226.8419.71Price / Sales15.68250.96391.39116.98Price / CashN/A65.8538.2534.62Price / Book6.856.466.794.50Net Income-$11.76M$143.98M$3.23B$248.18M7 Day Performance1.79%3.04%4.07%1.14%1 Month Performance21.84%7.44%12.52%15.18%1 Year Performance-5.64%-2.46%16.83%6.55% Addex Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ADXNAddex Therapeutics1.7042 of 5 stars$8.22-3.2%$30.00+264.8%-8.4%$8.72M$556,045.00-24.1930Gap UpBRNSBarinthus Biotherapeutics2.2934 of 5 stars$0.85-10.0%$5.17+507.8%-62.9%$34.29M$14.97M-0.57107AKTXAkari TherapeuticsN/A$1.26-0.5%N/A-16.2%$33.59MN/A0.009Analyst ForecastGap DownQNTMQuantum BiopharmaN/A$12.26+19.6%N/AN/A$33.18MN/A-0.80N/ANews CoverageEarnings ReportLVTXLAVA Therapeutics2.2336 of 5 stars$1.26+0.8%$3.17+151.3%-51.1%$33.14M$11.98M-1.2260Positive NewsEarnings ReportAnalyst RevisionCOEPCoeptis Therapeutics0.6986 of 5 stars$9.72-0.9%N/A+45.2%$32.71MN/A-1.682Positive NewsEarnings ReportSCLXScilex1.5518 of 5 stars$4.70+11.6%$455.00+9,580.9%-88.2%$32.67M$56.59M-5.6680High Trading VolumeSCYXSCYNEXIS1.2561 of 5 stars$0.83+5.3%N/A-69.5%$32.43M$3.75M-1.1260Positive NewsEarnings ReportDYAIDyadic International2.2941 of 5 stars$1.06+1.9%$6.00+466.0%-34.3%$31.90M$3.50M-4.617Positive NewsEarnings ReportFGENFibroGen4.4121 of 5 stars$0.31+2.5%$10.00+3,088.8%-71.3%$31.69M$7.00M-0.25570MAAQMana Capital AcquisitionN/A$3.84-4.0%N/A-26.2%$31.20MN/A0.001High Trading Volume Related Companies and Tools Related Companies Barinthus Biotherapeutics Alternatives Akari Therapeutics Alternatives Quantum Biopharma Alternatives LAVA Therapeutics Alternatives Coeptis Therapeutics Alternatives Scilex Alternatives SCYNEXIS Alternatives Dyadic International Alternatives FibroGen Alternatives Mana Capital Acquisition Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ADXN) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredElon Set to Shock the World on June 1st?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredMassive new energy source found in UtahNEW THIS WEEK: Huge Energy Discovery In Utah The Department of Energy say it could power America for millio...Stansberry Research | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Addex Therapeutics Ltd Please log in to your account or sign up in order to add this asset to your watchlist. Share Addex Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ADXN Stock Free ADXN Stock Alerts